IGPA Letter Regarding TGA Guidance titled “Evaluation of Biosimilars”

In an era when increasing demands are being made on the world’s healthcare services, generic medicines provide a major benefit to society by ensuring patient access to quality, safe and effective medicines while reducing the cost of pharmaceutical care. The International Generic Pharmaceutical Alliance (IGPA) was born as an international network of generic medicines associations, committed to promoting generic medicines and exchanging information worldwide.

Read More

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site